693 related articles for article (PubMed ID: 29096777)
1. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
[No Abstract] [Full Text] [Related]
3. Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
Schroder CM; Malow BA; Maras A; Melmed RD; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
J Autism Dev Disord; 2019 Aug; 49(8):3218-3230. PubMed ID: 31079275
[TBL] [Abstract][Full Text] [Related]
4. Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.
Malow BA; Findling RL; Schroder CM; Maras A; Breddy J; Nir T; Zisapel N; Gringras P
J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):252-261.e3. PubMed ID: 31982581
[TBL] [Abstract][Full Text] [Related]
5. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders.
Schroder CM; Banaschewski T; Fuentes J; Hill CM; Hvolby A; Posserud MB; Bruni O
Expert Opin Pharmacother; 2021 Dec; 22(18):2445-2454. PubMed ID: 34314281
[No Abstract] [Full Text] [Related]
6. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
Schröder CM; Broquère MA; Claustrat B; Delorme R; Franco P; Lecendreux M; Tordjman S
Encephale; 2022 Jun; 48(3):294-303. PubMed ID: 35120753
[TBL] [Abstract][Full Text] [Related]
7. Melatonin for insomnia in children.
Med Lett Drugs Ther; 2020 Jun; 62(1601):103-104. PubMed ID: 32724024
[No Abstract] [Full Text] [Related]
8. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
[TBL] [Abstract][Full Text] [Related]
9. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
Cortesi F; Giannotti F; Sebastiani T; Panunzi S; Valente D
J Sleep Res; 2012 Dec; 21(6):700-9. PubMed ID: 22616853
[TBL] [Abstract][Full Text] [Related]
12. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Weiss MD; Wasdell MB; Bomben MM; Rea KJ; Freeman RD
J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):512-519. PubMed ID: 16670647
[TBL] [Abstract][Full Text] [Related]
13. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
15. Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment.
Bruni O; Biggio G; Malorgio E; Nobili L
Sleep Med; 2024 Jul; 119():511-517. PubMed ID: 38805858
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
[TBL] [Abstract][Full Text] [Related]
17. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
Bendz LM; Scates AC
Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
[TBL] [Abstract][Full Text] [Related]
18. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
19. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
20. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
